SEARCH

SEARCH BY CITATION

References

  • Cataland S.R., Jin M., Ferketich A.K., Kennedy M.S., Kraut E.H., George J.N. & Wu H.M. (2007a) An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. British Journal of Haematology 136, 146149.
  • Cataland S.R., Jin M., Lin S., Kennedy M.S., Kraut E.H., George J.N. & Wu H.M. (2007b) Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. British Journal of Haematology 139, 486493.
  • Fakhouri F., Vernant J.P., Veyradier A., Wolf M., Kaplanski G., Binaut R., Rieger M., Scheiflinger F., Poullin P., Deroure B., Delarue R., Lesavre P., Vanhille P., Hermine O., Remuzzi G. & Grunfeld J.P. (2005) Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood 106, 19321937.
  • Fujikawa K., Suzuki H., McMullen B. & Chung D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98, 16621666.
  • Fujimura Y., Matsumoto M., Kokame K., Isonishi A., Soejima K., Akiyama N., Tomiyama J., Natori K., Kuranishi Y., Imamura Y., Inoue N., Higasa S., Seike M., Kozuka T., Hara M., Wada H., Murata M., Ikeda Y., Miyata T. & George J.N. (2008) Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. British Journal of Haematology 144, 742754.
  • Furlan M., Robles R. & Lamie B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87, 42234234.
  • Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P. & Lammle B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89, 30973103.
  • Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., Krause M., Scharrer I., Aumann V., Mittler U., Solenthaler M. & Lammle B. (1998a) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. The New England Journal of Medicine 339, 15781584.
  • Furlan M., Robles R., Solenthaler M. & Lammle B. (1998b) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91, 28392846.
  • Heidel F., Lipka D.B., Von Auer C., Huber C., Scharrer I. & Hess G. (2007) Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia. Thrombosis and Haemostasis 97, 228233.
  • Jasti S., Coyle T., Gentile T., Rosales L. & Poiesz B. (2008) Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature. Journal of Clinical Apheresis 23, 151156.
  • Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., Yang A.Y., Siemieniak D.R., Stark K.R., Gruppo R., Sarode R., Shurin S.B., Chandrasekaran V., Stabler S.P., Sabio H., Bouhassira E.E., Upshaw J.D. Jr, Ginsburg D. & Tsai H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413, 488494.
  • Malak S., Wolf M., Millot G.A., Mariotte E., Veyradier A., Meynard J.L., Korach J.M., Malot S., Bussel A., Azoulay E., Boulanger E., Galicier L., Devaux E., Eschwege V., Gallien S., Adrie C., Schlemmer B., Rondeau E. & Coppo P. (2008) Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity. Scandinavian Journal of Immunology 68, 337344.
  • McDonald V., Laffan M., Benjamin S., Bevan D., Machin S. & Scully M.A. (2008) Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. British Journal of Haematology 144, 430433.
  • Miller R.F., Scully M., Cohen H., Roedling S., Starke R., Edwards S.G. & Machin S.J. (2005) Thrombotic thrombocytopaenic purpura in HIV-infected patients. International Journal of STD & AIDS 16, 538542.
  • Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., Seder R.H., Hong S.L. & Deykin D. (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic.
  • Peyvandi F., Ferrari S., Lavoretano S., Canciani M.T. & Mannucci P.M. (2004) von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. British Journal of Haematology 127, 433439.
  • Peyvandi F., Siboni S.M., Lambertenghi D.D., Lavoretano S., De Fazio N., Moroni B., Lambertenghi D.G. & Mannuccio M.P. (2006) Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. British Journal of Haematology 134, 187195.
  • Peyvandi F., Lavoretano S., Palla R., Feys H.B., Vanhoorelbeke K., Battaglioli T., Valsecchi C., Canciani M.T., Fabris F., Zver S., Reti M., Mikovic D., Karimi M., Giuffrida G., Laurenti L. & Mannucci P.M. (2008) ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 93, 232239.
  • Rieger M., Mannucci P.M., Kremer Hovinga J.A., Herzog A., Gerstenbauer G., Konetschny C., Zimmermann K., Scharrer I., Peyvandi F., Galbusera M., Remuzzi G., Bohm M., Plaimauer B., Lammle B. & Scheiflinger F. (2005) ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 106, 12621267.
  • Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C. & Spasoff R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. The New England Journal of Medicine 325, 393397.
  • Sanchez-Luceros A., Farias C.E., Amaral M.M., Kempfer A.C., Votta R., Marchese C., Salviu M.J., Woods A.I., Meschengieser S.S. & Lazzari M.A. (2004) von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thrombosis and Haemostasis 92, 13201326.
  • Scheiflinger F., Knobl P., Trattner B., Plaimauer B., Mohr G., Dockal M., Dorner F. & Rieger M. (2003) Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Blood 102, 32413243.
  • Scully M., Starke R., Lee R., Mackie I., Machin S. & Cohen H. (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagulation & Fibrinolysis 17, 459463.
  • Scully M., Cohen H., Cavenagh J., Benjamin S., Starke R., Killick S., Mackie I. & Machin S.J. (2007) Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. British Journal of Haematology 136, 451461.
  • Scully M., Liesner R., Burgess C., Lawrie A. & Machin S. (2008a) ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions. British Journal of Haematology 141, 262265.
  • Scully M., Yarranton H., Liesner R., Cavenagh J., Hunt B., Benjamin S., Bevan D., Mackie I. & Machin S. (2008b) Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features. British Journal of Haematology 142, 819826.
  • Terrell D.R., Williams L.A., Vesely S.K., Lammle B., Hovinga J.A. & George J.N. (2005) The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. Journal of Thrombosis and Haemostasis 3, 14321436.
  • Tsai H.M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87, 42354244.
  • Tsai H.M. & Lian E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. The New England Journal of Medicine, 339, 15851594.
  • Vesely S.K., Li X., McMinn J.R., Terrell D.R. & George J.N. (2004) Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 44, 11491158.
  • Zheng X., Chung D., Takayama T.K., Majerus E.M., Sadler J.E. & Fujikawa K. (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. The Journal of Biological Chemistry 276, 4105941063.
  • Zheng X.L., Kaufman R.M., Goodnough L.T. & Sadler J.E. (2004) Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 103, 40434049.